Bibliographic information
GuidelineGuidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
Originally developed
CHRONIC HEPATITIS B. Relapse may occur after stopping therapy with nucleos(t)ide analogues (NAs). Retreatment is recommended if there are consistent signs of reactivation (HBsAg or HBeAg becomes positive, ALT levels increase, or HBV DNA becomes detectable again) (where HBV DNA testing is available).
Recommended in favor
Strong
Certainty of evidence
Low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year2024
InstitutionWHO